Guangzhou Jet Bio-Filtration Co., Ltd.

XSSC:688026 Stock Report

Market Cap: CN¥1.7b

Guangzhou Jet Bio-Filtration Past Earnings Performance

Past criteria checks 4/6

Guangzhou Jet Bio-Filtration's earnings have been declining at an average annual rate of -16.1%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 5.8% per year. Guangzhou Jet Bio-Filtration's return on equity is 6.1%, and it has net margins of 13.5%.

Key information

-16.1%

Earnings growth rate

-19.1%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate5.8%
Return on equity6.1%
Net Margin13.5%
Next Earnings Update16 Apr 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Guangzhou Jet Bio-Filtration makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:688026 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24524716625
30 Jun 24503626525
31 Mar 24487526228
31 Dec 23463356129
30 Sep 23459165631
30 Jun 23457215734
31 Mar 23494385535
31 Dec 22610885537
30 Sep 227041065846
30 Jun 228051485648
31 Mar 228721646249
31 Dec 218561716344
30 Sep 217591414635
30 Jun 216351025530
31 Mar 216031344726
31 Dec 205041193824
30 Sep 204631525322
30 Jun 204221523618
31 Mar 20291943313
31 Dec 19247663213
30 Sep 19244635016
31 Dec 1820753309
30 Sep 181774618
31 Dec 1716740238
30 Sep 1715537290
30 Jun 1714234270
31 Mar 1713330260
31 Dec 1612426208
30 Sep 1611422260
30 Jun 1610418250
31 Mar 1610316240
31 Dec 1510313240
31 Dec 14888230

Quality Earnings: 688026 has high quality earnings.

Growing Profit Margin: 688026's current net profit margins (13.5%) are higher than last year (3.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688026's earnings have declined by 16.1% per year over the past 5 years.

Accelerating Growth: 688026's earnings growth over the past year (341.6%) exceeds its 5-year average (-16.1% per year).

Earnings vs Industry: 688026 earnings growth over the past year (341.6%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 688026's Return on Equity (6.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 08:28
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangzhou Jet Bio-Filtration Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Kai WangCitic Securities Co., Ltd.